Covea Finance Portfolio Activity: Significant Changes in Q2 2026

As reported for the period ending June 30th, 2026, Covea Finance, a prominent financial investor, has disclosed significant changes to its portfolio holdings. This analysis focuses on observable buys and sells during this quarter.

The investment firm demonstrated considerable buying activity in several areas:

• They significantly increased their position in Canadian Pacific Kansas City (CP), acquiring 243,425 shares. This resulted in a substantial portfolio allocation increase.
• Covea Finance also made notable additions to their holdings of Gilead Sciences (GILD) and Orlan Management Ltd. New (ORLA).
• In the Technology sector, they added shares of On Semiconductor (ON), acquiring all 103,613 shares available in this transaction.

Conversely, Covea Finance reported substantial sales during the quarter:

• The firm sold a large number of shares in Microsoft (MSFT), reducing its stake by 161,500 shares. This sale was significant enough to impact the overall portfolio allocation.
• They also disposed of a considerable portion of their holdings in McCormick & Co (MKC), selling 260,700 shares previously held.
• Furthermore, Covea Finance exited a position entirely by selling all 53,246 shares of Abbott Laboratories (ABT).

These transactions reflect the dynamic nature of Covea Finance's investment strategy. The firm simultaneously scaled up positions in certain companies while divesting substantial stakes or entire holdings from others.

In addition to these major movements, there were other noteworthy changes:

• The investor noted a significant increase in United States Antimony Corp (UAMY) shares.
• They also purchased additional shares of MP Materials Corp (MP).

Covea Finance's portfolio now includes a diverse range of sectors, with Technology remaining the largest allocation at 33.04%, followed by Industrials and Consumer Cyclical.